For research use only · Not for human consumption
The Compound Effect
Catalog
CJC-1295 with DAC — The Compound Effect vial

GH research

CJC-1295 with DAC

Price TBD · USD

Vial size: TBD

CJC-1295 with DAC is a modified GHRH analogue incorporating a drug affinity complex intended to enable albumin binding. The DAC form is distinct from products sold as modified GRF (1–29) or CJC-1295 without DAC.

Compound identity

Modified GHRH analogue with an albumin-binding modification

Research context

GHRH-receptor signaling and the effects of albumin binding on experimental pharmacokinetics.

Product specifications

Vial quantity
Awaiting confirmation
Batch identity & purity
Report not supplied
Intended use
Laboratory research only

Photo labels are not batch certificates and do not confirm the supplied quantity, identity or purity.

Handling & documentation

Qualified researchers should obtain the supplier's safety data sheet, batch certificate and material-specific storage instructions before use. Preparation, solvent selection and experimental concentrations must follow a validated laboratory protocol; no human dosing or administration instructions are provided.

Research safety FAQ

For research use only. Not for human consumption.